TZ2
A dual GIP and GLP-1 receptor agonist studied for incretin-pathway signaling and metabolic regulation.
Research Overview
TZ2 is a synthetic 39-amino-acid peptide engineered as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. In research models it is studied for the combined activation of both incretin pathways and downstream effects on insulin secretion, glucose homeostasis, and energy metabolism.
Its dual-receptor mechanism is the principal distinction from single GLP-1 agonists, making it a key reference compound in comparative incretin and metabolic-pathway research.
Specifications
| Compound | TZ2 (LY3298176) |
| Classification | Metabolic research compound |
| Molecular weight | 4,813.45 g/mol |
| Sequence / Form | Synthetic 39-aa dual-incretin agonist |
| Purity | ≥99% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
Quality Documentation
Every released lot is supported by quality-control documentation. Certificate access is presented by compound and lot where available. Cold-chain shipping is available where required; inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
Research Use Only
This product is offered strictly for laboratory research use. It is not a drug, food, cosmetic, supplement, or consumer product, and is not intended for human or veterinary use.
